Coffee, CYP1A2 genotype, and risk of myocardial infarction

被引:318
|
作者
Cornelis, MC
El-Sohemy, A
Kabagambe, EK
Campos, H
机构
[1] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada
[2] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA
[3] Univ Costa Rica, Ctr Centroamer Poblac, San Pedro Montes de Oca, Costa Rica
来源
关键词
D O I
10.1001/jama.295.10.1135
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The association between coffee intake and risk of myocardial infarction (MI) remains controversial. Coffee is a major source of caffeine, which is metabolized by the polymorphic cytochrome P450 1A2 (CYP1A2) enzyme. Individuals who are homozygous for the CYP1A2*1A allele are "rapid" caffeine metabolizers, whereas carriers of the variant CYP1A2*1F are "slow" caffeine metabolizers. Objective To determine whether CYP1A2 genotype modifies the association between coffee consumption and risk of acute nonfatal MI. Design, Setting, and Participants Cases (n = 2014) with a first acute nonfatal MI and population-based controls (n = 2014) living in Costa Rica between 1994 and 2004, matched for age, sex, and area of residence, were genotyped by restriction fragment length polymorphism polymerase chain reaction. A food frequency questionnaire was used to assess the intake of caffeinated coffee. Main Outcome Measure Relative risk of nonfatal MI associated with coffee intake, calculated using unconditional logistic regression. Results Fifty-five percent of cases (n = 1114) and 54% of controls (n = 1082) were carriers of the slow *1F allele. For carriers of the slow *1F allele, the multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of nonfatal MI associated with consuming less than 1, 1, 2 to 3, and 4 or more cups of coffee per day were 1.00 ( reference), 0.99 (0.69-1.44), 1.36 (1.01-1.83), and 1.64 (1.14-2.34), respectively. Corresponding ORs ( 95% CIs) for individuals with the rapid *1A/*1A genotype were 1.00, 0.75 (0.51-1.12), 0.78 (0.56-1.09), and 0.99 (0.66-1.48) (P = .04 for gene X coffee interaction). For individuals younger than the median age of 59 years, the ORs ( 95% CIs) associated with consuming less than 1, 1, 2 to 3, or 4 or more cups of coffee per day were 1.00, 1.24 (0.71-2.18), 1.67 (1.08-2.60), and 2.33 (1.39-3.89), respectively, among carriers of the *1F allele. The corresponding ORs ( 95% CIs) for those with the *1A/*1A genotype were 1.00, 0.48 (0.26-0.87), 0.57 (0.35-0.95), and 0.83 (0.46-1.51). Conclusion Intake of coffee was associated with an increased risk of nonfatal MI only among individuals with slow caffeine metabolism, suggesting that caffeine plays a role in this association.
引用
收藏
页码:1135 / 1141
页数:7
相关论文
共 50 条
  • [21] Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
    Djordjevic, Natasa
    Ghotbi, Roza
    Bertilsson, Leif
    Jankovic, Slobodan
    Aklillu, Eleni
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (04) : 381 - 385
  • [22] Induction of CYP1A2 by heavy coffee consumption in Serbs and Swedes
    Natasa Djordjevic
    Roza Ghotbi
    Leif Bertilsson
    Slobodan Jankovic
    Eleni Aklillu
    European Journal of Clinical Pharmacology, 2008, 64 : 381 - 385
  • [23] Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients
    Palatini, Paolo
    Benetti, Elisabetta
    Mos, Lucio
    Garavelli, Guido
    Mazzer, Adriano
    Cozzio, Susanna
    Fania, Claudio
    Casiglia, Edoardo
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2015, 30 (03) : 209 - 217
  • [24] Association of coffee consumption and CYP1A2 polymorphism with risk of impaired fasting glucose in hypertensive patients
    Paolo Palatini
    Elisabetta Benetti
    Lucio Mos
    Guido Garavelli
    Adriano Mazzer
    Susanna Cozzio
    Claudio Fania
    Edoardo Casiglia
    European Journal of Epidemiology, 2015, 30 : 209 - 217
  • [25] High Coffee Intake, but Not Caffeine, is Associated with Reduced Estrogen Receptor Negative and Postmenopausal Breast Cancer Risk with No Effect Modification by CYP1A2 Genotype
    Lowcock, Elizabeth C.
    Cotterchio, Michelle
    Anderson, Laura N.
    Boucher, Beatrice A.
    El-Sohemy, Ahmed
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2013, 65 (03): : 398 - 409
  • [26] Caffeine, CYP1A2 genotype, and sports performance: is timing important?
    Pickering, Craig
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (01) : 349 - 350
  • [27] CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy
    Djordjevic, Natasa
    Milovanovic, Dragana Dragas
    Radovanovic, Marija
    Radosavljevic, Ivan
    Obradovic, Slobodan
    Jakovljevic, Mihajlo
    Milovanovic, Dragan
    Milovanovic, Jasmina R.
    Jankovic, Slobodan
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (04) : 439 - 445
  • [28] Association of caffeine intake and CYP1A2 genotype with ovarian cancer
    Goodman, MT
    Tung, KH
    McDuffie, K
    Wilkens, LR
    Donlon, TA
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2003, 46 (01): : 23 - 29
  • [29] CYP1A2 genotype affects carbamazepine pharmacokinetics in children with epilepsy
    Natasa Djordjevic
    Dragana Dragas Milovanovic
    Marija Radovanovic
    Ivan Radosavljevic
    Slobodan Obradovic
    Mihajlo Jakovljevic
    Dragan Milovanovic
    Jasmina R. Milovanovic
    Slobodan Jankovic
    European Journal of Clinical Pharmacology, 2016, 72 : 439 - 445
  • [30] Caffeine, CYP1A2 genotype, and sports performance: is timing important?
    Craig Pickering
    Irish Journal of Medical Science (1971 -), 2019, 188 : 349 - 350